{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:10:40Z","timestamp":1791159040119,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1038\/ncpcardio1086","type":"journal-article","created":{"date-parts":[[2008,1,25]],"date-time":"2008-01-25T08:58:01Z","timestamp":1201251481000},"page":"91-102","source":"Crossref","is-referenced-by-count":163,"title":["Rapid regression of atherosclerosis: insights from the clinical and experimental literature"],"prefix":"10.1038","volume":"5","author":[{"given":"Kevin Jon","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Feig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpcardio1086_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/01.ATV.14.2.177","volume":"14","author":"DH Blankenhorn","year":"1994","unstructured":"Blankenhorn DH and Hodis HN (1994) George Lyman Duff Memorial Lecture: arterial imaging and atherosclerosis reversal. Arterioscler Thromb 14: 177\u2013192","journal-title":"Arterioscler Thromb"},{"key":"BFncpcardio1086_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.ATV.21.2.183","volume":"21","author":"Y Stein","year":"2001","unstructured":"Stein Y and Stein O (2001) Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions? Arterioscler Thromb Vasc Biol 21: 183\u2013188","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR3","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker R and Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381\u20131478","journal-title":"Physiol Rev"},{"key":"BFncpcardio1086_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801\u2013809","journal-title":"Nature"},{"key":"BFncpcardio1086_CR5","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1073\/pnas.70.6.1753","volume":"70","author":"EP Benditt","year":"1973","unstructured":"Benditt EP and Benditt JM (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70: 1753\u20131756","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpcardio1086_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1749-6632.1976.tb43368.x","volume":"275","author":"RW Wissler","year":"1976","unstructured":"Wissler RW and Vesselinovitch D (1976) Studies of regression of advanced atherosclerosis in experimental animals and man. Ann N Y Acad Sci 275: 363\u2013378","journal-title":"Ann N Y Acad Sci"},{"key":"BFncpcardio1086_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/hrt.69.5.377","volume":"69","author":"MJ Davies","year":"1993","unstructured":"Davies MJ  et al. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377\u2013381","journal-title":"Br Heart J"},{"key":"BFncpcardio1086_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3181\/00379727-95-23300","volume":"95","author":"M Friedman","year":"1957","unstructured":"Friedman M  et al. (1957) Resolution of aortic atherosclerotic infiltration in the rabbit by phosphatide infusion. Proc Soc Exp Biol Med 95: 586\u2013588","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFncpcardio1086_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1353\/pbm.1984.0031","volume":"27","author":"KJ Williams","year":"1984","unstructured":"Williams KJ  et al. (1984) Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect Biol Med 27: 417\u2013431","journal-title":"Perspect Biol Med"},{"key":"BFncpcardio1086_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/pgmj.52.609.456","volume":"52","author":"ML Armstrong","year":"1976","unstructured":"Armstrong ML (1976) Evidence of regression of atherosclerosis in primates and man. Postgrad Med J 52: 456\u2013461","journal-title":"Postgrad Med J"},{"key":"BFncpcardio1086_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0021-9150(83)90097-7","volume":"48","author":"MR Malinow","year":"1983","unstructured":"Malinow MR (1983) Experimental models of atherosclerosis regression. Atherosclerosis 48: 105\u2013118","journal-title":"Atherosclerosis"},{"key":"BFncpcardio1086_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0368-1319(68)80060-2","volume":"8","author":"CA Maruffo","year":"1968","unstructured":"Maruffo CA and Portman OW (1968) Nutritional control of coronary artery atherosclerosis in the squirrel monkey. J Atheroscler Res 8: 237\u2013247","journal-title":"J Atheroscler Res"},{"key":"BFncpcardio1086_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/01.RES.27.1.59","volume":"27","author":"ML Armstrong","year":"1970","unstructured":"Armstrong ML  et al. (1970) Regression of coronary atheromatosis in rhesus monkeys. Circ Res 27: 59\u201367","journal-title":"Circ Res"},{"key":"BFncpcardio1086_CR14","first-page":"233","volume":"105","author":"AS Daoud","year":"1981","unstructured":"Daoud AS  et al. (1981) Sequential morphologic studies of regression of advanced atherosclerosis. Arch Pathol Lab Med 105: 233\u2013239","journal-title":"Arch Pathol Lab Med"},{"key":"BFncpcardio1086_CR15","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1161\/01.ATV.0000174795.62387.d3","volume":"25","author":"KJ Williams","year":"2005","unstructured":"Williams KJ and Tabas I (2005) Lipoprotein retention\u2014and clues for atheroma regression. Arterioscler Thromb Vasc Biol 25: 1536\u20131540","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0005-2760(86)90167-0","volume":"875","author":"KJ Williams","year":"1986","unstructured":"Williams KJ and Scanu AM (1986) Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim Biophys Acta 875: 183\u2013194","journal-title":"Biochim Biophys Acta"},{"key":"BFncpcardio1086_CR17","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/01.ATV.17.10.2132","volume":"17","author":"WV Rodrigueza","year":"1997","unstructured":"Rodrigueza WV  et al. (1997) Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools: implications for the treatment of atherosclerosis. Arterioscler Thromb Vasc Biol 17: 2132\u20132139","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/01.ATV.20.4.1033","volume":"20","author":"KJ Williams","year":"2000","unstructured":"Williams KJ  et al. (2000) Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol 20: 1033\u20131039","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/01.ATV.17.2.383","volume":"17","author":"WV Rodrigueza","year":"1997","unstructured":"Rodrigueza WV  et al. (1997) Remodeling and shuttling: mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler Thromb Vasc Biol 17: 383\u2013393","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0169-409X(97)00130-0","volume":"32","author":"KJ Williams","year":"1998","unstructured":"Williams KJ  et al. (1998) Structural and metabolic consequences of liposome\u2013lipoprotein interactions. Adv Drug Deliv Rev 32: 31\u201343","journal-title":"Adv Drug Deliv Rev"},{"key":"BFncpcardio1086_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0005-2736(97)00198-3","volume":"1368","author":"WV Rodrigueza","year":"1998","unstructured":"Rodrigueza WV  et al. (1998) Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles. Biochim Biophys Acta 1368: 306\u2013320","journal-title":"Biochim Biophys Acta"},{"key":"BFncpcardio1086_CR22","first-page":"a-53","volume":"22","author":"DJ Rader","year":"2002","unstructured":"Rader DJ  et al. (2002) Infusion of large unilamellar vesicles (ETC-588) mobilize unesterified cholesterol in a dose-dependent fashion in healthy volunteers [abstract]. Arterioscler Thromb Vasc Biol 22: a-53","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR23","first-page":"223","volume-title":"US Patent 5","author":"KJ Williams","year":"1998","unstructured":"Williams KJ (1998) Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis. US Patent 5, 746, 223"},{"key":"BFncpcardio1086_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/01.ATV.15.11.1882","volume":"15","author":"A Miyazaki","year":"1995","unstructured":"Miyazaki A  et al. (1995) Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 15: 1882\u20131888","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1749-6632.2000.tb06309.x","volume":"902","author":"M Aikawa","year":"2000","unstructured":"Aikawa M and Libby P (2000) Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma. Ann NY Acad Sci 902: 140\u2013152","journal-title":"Ann NY Acad Sci"},{"key":"BFncpcardio1086_CR26","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1016\/S0021-9258(18)83374-9","volume":"264","author":"A Walsh","year":"1989","unstructured":"Walsh A  et al. (1989) High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J Biol Chem 264: 6488\u20136494","journal-title":"J Biol Chem"},{"key":"BFncpcardio1086_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","volume":"71","author":"AS Plump","year":"1992","unstructured":"Plump AS  et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343\u2013353","journal-title":"Cell"},{"key":"BFncpcardio1086_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI116663","volume":"92","author":"S Ishibashi","year":"1993","unstructured":"Ishibashi S  et al. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883\u2013893","journal-title":"J Clin Invest"},{"key":"BFncpcardio1086_CR29","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","volume":"100","author":"RK Tangirala","year":"1999","unstructured":"Tangirala RK  et al. (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100: 1816\u20131822","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR30","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1161\/hc2501.092494","volume":"103","author":"PK Shah","year":"2001","unstructured":"Shah PK  et al. (2001) High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice: potential implications for acute plaque stabilization. Circulation 103: 3047\u20133050","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR31","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/hc4501.098952","volume":"104","author":"JX Rong","year":"2001","unstructured":"Rong JX  et al. (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104: 2447\u20132452","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"C Wolfrum","year":"2005","unstructured":"Wolfrum C  et al. (2005) Apolipoprotein M is required for pre\u03b2-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11: 418\u2013422","journal-title":"Nat Med"},{"key":"BFncpcardio1086_CR33","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1016\/S0021-9258(18)42208-9","volume":"267","author":"KJ Williams","year":"1992","unstructured":"Williams KJ  et al. (1992) Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem 267: 13284\u201313292","journal-title":"J Biol Chem"},{"key":"BFncpcardio1086_CR34","doi-asserted-by":"publisher","first-page":"10160","DOI":"10.1016\/S0021-9258(18)82186-X","volume":"268","author":"ZS Ji","year":"1993","unstructured":"Ji ZS  et al. (1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem 268: 10160\u201310167","journal-title":"J Biol Chem"},{"key":"BFncpcardio1086_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2337\/diabetes.54.4.1116","volume":"54","author":"KJ Williams","year":"2005","unstructured":"Williams KJ  et al. (2005) Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. Diabetes 54: 1116\u20131122","journal-title":"Diabetes"},{"key":"BFncpcardio1086_CR36","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1172\/JCI118200","volume":"96","author":"VS Kashyap","year":"1995","unstructured":"Kashyap VS  et al. (1995) Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 96: 1612\u20131620","journal-title":"J Clin Invest"},{"key":"BFncpcardio1086_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1172\/JCI119501","volume":"100","author":"K Tsukamoto","year":"1997","unstructured":"Tsukamoto K  et al. (1997) Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest 100: 107\u2013114","journal-title":"J Clin Invest"},{"key":"BFncpcardio1086_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1074\/jbc.M003324200","volume":"276","author":"RK Tangirala","year":"2001","unstructured":"Tangirala RK  et al. (2001) Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276: 261\u2013266","journal-title":"J Biol Chem"},{"key":"BFncpcardio1086_CR39","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1161\/01.ATV.20.8.1939","volume":"20","author":"FE Thorngate","year":"2000","unstructured":"Thorngate FE  et al. (2000) Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 20: 1939\u20131945","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/01.ATV.0000134297.61979.3c","volume":"24","author":"H Wientgen","year":"2004","unstructured":"Wientgen H  et al. (2004) Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24: 1460\u20131465","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/hmg\/11.1.43","volume":"11","author":"JD Harris","year":"2002","unstructured":"Harris JD  et al. (2002) Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE. Hum Mol Genet 11: 43\u201358","journal-title":"Hum Mol Genet"},{"key":"BFncpcardio1086_CR42","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1161\/01.ATV.20.12.2587","volume":"20","author":"ME Rosenfeld","year":"2000","unstructured":"Rosenfeld ME  et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20: 2587\u20132592","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1067\/mva.2001.115963","volume":"34","author":"ED Reis","year":"2001","unstructured":"Reis ED  et al. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg 34: 541\u2013547","journal-title":"J Vasc Surg"},{"key":"BFncpcardio1086_CR44","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1073\/pnas.0403259101","volume":"101","author":"J Llodra","year":"2004","unstructured":"Llodra J  et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101: 11779\u201311784","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpcardio1086_CR45","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1073\/pnas.0511043103","volume":"103","author":"E Trogan","year":"2006","unstructured":"Trogan E  et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci USA 103: 3781\u20133786","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpcardio1086_CR46","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/01.ATV.0000139313.69015.1c","volume":"24","author":"E Trogan","year":"2004","unstructured":"Trogan E  et al. (2004) Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol 24: 1714\u20131719","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","volume":"21","author":"V Angeli","year":"2004","unstructured":"Angeli V  et al. (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21: 561\u2013574","journal-title":"Immunity"},{"key":"BFncpcardio1086_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3121\/cmr.3.3.166","volume":"3","author":"MA Wallet","year":"2005","unstructured":"Wallet MA  et al. (2005) Immunoregulation of dendritic cells. Clin Med Res 3: 166\u2013175","journal-title":"Clin Med Res"},{"key":"BFncpcardio1086_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340: 115\u2013126","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245\u2013252","journal-title":"Nature"},{"key":"BFncpcardio1086_CR51","first-page":"221","volume":"293","author":"E Trogan","year":"2005","unstructured":"Trogan E and Fisher EA (2005) Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions. Methods Mol Biol 293: 221\u2013231","journal-title":"Methods Mol Biol"},{"key":"BFncpcardio1086_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R Forster","year":"1999","unstructured":"Forster R  et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23\u201333","journal-title":"Cell"},{"key":"BFncpcardio1086_CR53","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","volume":"294","author":"A Chawla","year":"2001","unstructured":"Chawla A  et al. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866\u20131870","journal-title":"Science"},{"key":"BFncpcardio1086_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/01.ATV.0000150044.84012.68","volume":"25","author":"N Levin","year":"2005","unstructured":"Levin N  et al. (2005) Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 25: 135\u2013142","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.med.57.121304.131428","volume":"57","author":"SW Beaven","year":"2006","unstructured":"Beaven SW and Tontonoz P (2006) Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 57: 313\u2013329","journal-title":"Annu Rev Med"},{"key":"BFncpcardio1086_CR56","first-page":"e-50","volume":"26","author":"JE Feig","year":"2006","unstructured":"Feig JE  et al. (2006) CCR7 is functionally required for atherosclerosis regression and is activated by LXR [abstract]. Arterioscler Thromb Vasc Biol 26: e-50","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR57","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1161\/01.CIR.0000054781.50889.0C","volume":"107","author":"HD Lieu","year":"2003","unstructured":"Lieu HD  et al. (2003) Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107: 1315\u20131321","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR58","first-page":"e-72","volume":"24","author":"JX Rong","year":"2004","unstructured":"Rong JX  et al. (2004) Normalization of plasma total cholesterol in LDL receptor deficient (Ldlr\u2212\/\u2212), apoB100 mice decreases the size and macrophage content of advanced atherosclerotic lesions [abstract]. Arterioscler Thromb Vasc Biol 24: e-72","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR59","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1074\/jbc.M111222200","volume":"277","author":"RL Raffai","year":"2002","unstructured":"Raffai RL and Weisgraber KH (2002) Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biol Chem 277: 11064\u201311068","journal-title":"J Biol Chem"},{"key":"BFncpcardio1086_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/01.ATV.0000152613.83243.12","volume":"25","author":"RL Raffai","year":"2005","unstructured":"Raffai RL  et al. (2005) Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Arterioscler Thromb Vasc Biol 25: 436\u2013441","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR61","first-page":"241","volume":"99","author":"CR Ost","year":"1967","unstructured":"Ost CR and Stenson S (1967) Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid. Scand J Clin Lab Invest Suppl 99: 241\u2013245","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"BFncpcardio1086_CR62","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","volume":"87","author":"BG Brown","year":"1993","unstructured":"Brown BG  et al. (1993) Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87: 1781\u20131791","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR63","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/pcad.2002.123474","volume":"44","author":"JA Farmer","year":"2002","unstructured":"Farmer JA and Gotto AM Jr (2002) Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis 44: 415\u2013428","journal-title":"Prog Cardiovasc Dis"},{"key":"BFncpcardio1086_CR64","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","volume":"15","author":"HC Stary","year":"1995","unstructured":"Stary HC  et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15: 1512\u20131531","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR65","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa011090","volume":"345","author":"BG Brown","year":"2001","unstructured":"Brown BG  et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345: 1583\u20131592","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR66","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","volume":"339","author":"TQ Callister","year":"1998","unstructured":"Callister TQ  et al. (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972\u20131978","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR67","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","volume":"291","author":"SE Nissen","year":"2004","unstructured":"Nissen SE  et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291: 1071\u20131080","journal-title":"JAMA"},{"key":"BFncpcardio1086_CR68","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","volume":"295","author":"SE Nissen","year":"2006","unstructured":"Nissen SE  et al. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295: 1556\u20131565","journal-title":"JAMA"},{"key":"BFncpcardio1086_CR69","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486\u20132497","DOI":"10.1001\/jama.285.19.2486"},{"key":"BFncpcardio1086_CR70","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","volume":"46","author":"SD Wiviott","year":"2005","unstructured":"Wiviott SD  et al. (2005) Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46: 1411\u20131416","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1086_CR71","doi-asserted-by":"publisher","first-page":"18L","DOI":"10.1016\/S0002-9149(02)02957-0","volume":"90","author":"DH O'Leary","year":"2002","unstructured":"O'Leary DH and Polak JF (2002) Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90: 18L\u201321L","journal-title":"Am J Cardiol"},{"key":"BFncpcardio1086_CR72","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1185\/030079906X148508","volume":"22","author":"AJ Taylor","year":"2006","unstructured":"Taylor AJ  et al. (2006) The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3. Curr Med Res Opin 22: 2243\u20132250","journal-title":"Curr Med Res Opin"},{"key":"BFncpcardio1086_CR73","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","volume":"110","author":"AJ Taylor","year":"2004","unstructured":"Taylor AJ  et al. (2004) Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110: 3512\u20133517","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR74","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE  et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290: 2292\u20132300","journal-title":"JAMA"},{"key":"BFncpcardio1086_CR75","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","volume":"297","author":"JC Tardif","year":"2007","unstructured":"Tardif JC  et al. (2007) Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297: 1675\u20131682","journal-title":"JAMA"},{"key":"BFncpcardio1086_CR76","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ  et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357: 2109\u20132122","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR77","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa070635","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE  et al. (2007) Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356: 1304\u20131316","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR78","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa071359","volume":"356","author":"JJ Kastelein","year":"2007","unstructured":"Kastelein JJ  et al. (2007) Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 356: 1620\u20131630","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR79","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1172\/JCI118751","volume":"97","author":"S Zhong","year":"1996","unstructured":"Zhong S  et al. (1996) Increased coronary heart disease in Japanese\u2013American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97: 2917\u20132923","journal-title":"J Clin Invest"},{"key":"BFncpcardio1086_CR80","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1194\/jlr.M300520-JLR200","volume":"45","author":"JD Curb","year":"2004","unstructured":"Curb JD  et al. (2004) A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 45: 948\u2013953","journal-title":"J Lipid Res"},{"key":"BFncpcardio1086_CR81","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S1359-6446(05)03514-2","volume":"10","author":"ME Brousseau","year":"2005","unstructured":"Brousseau ME (2005) Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov Today 10: 1095\u20131101","journal-title":"Drug Discov Today"},{"key":"BFncpcardio1086_CR82","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.297.5.499","volume":"297","author":"SJ Nicholls","year":"2007","unstructured":"Nicholls SJ  et al. (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297: 499\u2013508","journal-title":"JAMA"},{"key":"BFncpcardio1086_CR83","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","volume":"15","author":"KJ Williams","year":"1995","unstructured":"Williams KJ and Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15: 551\u2013561","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR84","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","volume":"417","author":"K Sk\u00e5l\u00e9n","year":"2002","unstructured":"Sk\u00e5l\u00e9n K  et al. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417: 750\u2013754","journal-title":"Nature"},{"key":"BFncpcardio1086_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/hq0102.101551","volume":"22","author":"MO Pentikainen","year":"2002","unstructured":"Pentikainen MO  et al. (2002) Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler Thromb Vasc Biol 22: 211\u2013217","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR86","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCRESAHA.107.149666","volume":"101","author":"M Gustafsson","year":"2007","unstructured":"Gustafsson M  et al. (2007) Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res 101: 777\u2013783","journal-title":"Circ Res"},{"key":"BFncpcardio1086_CR87","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11883-004-0099-1","volume":"6","author":"N Watanabe","year":"2004","unstructured":"Watanabe N and Ikeda U (2004) Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6: 112\u2013120","journal-title":"Curr Atheroscler Rep"},{"key":"BFncpcardio1086_CR88","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/01.ATV.0000254674.47693.e8","volume":"27","author":"ML Liu","year":"2007","unstructured":"Liu ML  et al. (2007) Cholesterol enrichment of human monocyte\/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol 27: 430\u2013435","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR89","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.CIR.22.4.547","volume":"22","author":"H Field Jr","year":"1960","unstructured":"Field H Jr  et al. (1960) Dynamic aspects of cholesterol metabolism in different areas of the aorta and other tissues in man and their relationship to atherosclerosis. Circulation 22: 547\u2013558","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR90","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1172\/JCI107772","volume":"54","author":"SN Jagannathan","year":"1974","unstructured":"Jagannathan SN  et al. (1974) The turnover of cholesterol in human atherosclerotic arteries. J Clin Invest 54: 366\u2013377","journal-title":"J Clin Invest"},{"key":"BFncpcardio1086_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.ATV.16.1.4","volume":"16","author":"JR Guyton","year":"1996","unstructured":"Guyton JR and Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16: 4\u201311","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1086_CR92","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0022-2275(20)38701-0","volume":"28","author":"CH Sloop","year":"1987","unstructured":"Sloop CH  et al. (1987) Interstitial fluid lipoproteins. J Lipid Res 28: 225\u2013237","journal-title":"J Lipid Res"},{"key":"BFncpcardio1086_CR93","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1021\/nl061498r","volume":"6","author":"JC Frias","year":"2006","unstructured":"Frias JC  et al. (2006) Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett 6: 2220\u20132224","journal-title":"Nano Lett"},{"key":"BFncpcardio1086_CR94","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1161\/01.CIR.0000070934.69310.1A","volume":"107","author":"RJ Bisoendial","year":"2003","unstructured":"Bisoendial RJ  et al. (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107: 2944\u20132948","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR95","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jacc.2004.06.028","volume":"44","author":"S Kaul","year":"2004","unstructured":"Kaul S  et al. (2004) Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex. J Am Coll Cardiol 44: 1311\u20131319","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1086_CR96","first-page":"30","volume":"9","author":"P Constantinides","year":"1981","unstructured":"Constantinides P (1981) Overview of studies on regression of atherosclerosis. Artery 9: 30\u201343","journal-title":"Artery"},{"key":"BFncpcardio1086_CR97","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMe058052","volume":"352","author":"B Pitt","year":"2005","unstructured":"Pitt B (2005) Low-density lipoprotein cholesterol in patients with stable coronary heart disease\u2014is it time to shift our goals? N Engl J Med 352: 1483\u20131484","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR98","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","volume":"114","author":"JJ Kastelein","year":"2006","unstructured":"Kastelein JJ  et al. (2006) Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation 114: 1729\u20131735","journal-title":"Circulation"},{"key":"BFncpcardio1086_CR99","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa061189","volume":"356","author":"M Cuchel","year":"2007","unstructured":"Cuchel M  et al. (2007) Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 356: 148\u2013156","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR100","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1056\/NEJMe0707210","volume":"357","author":"DJ Rader","year":"2007","unstructured":"Rader DJ (2007) Illuminating HDL\u2014is it still a viable therapeutic target? N Engl J Med 357: 2180\u20132183","journal-title":"N Engl J Med"},{"key":"BFncpcardio1086_CR101","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1527-3466.2003.tb00120.x","volume":"21","author":"GB Zavoico","year":"2003","unstructured":"Zavoico GB (2003) Emerging Cardiovascular Therapeutics. Cambridge, MA, USA, June 10\u201311, 2003. Cardiovasc Drug Rev 21: 246\u2013253","journal-title":"Cardiovasc Drug Rev"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T16:31:24Z","timestamp":1650040284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["BFncpcardio1086"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio1086","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}